Skip to main content

Glucotrack, Inc.

GCTK
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001506983

No open-market purchases or sales by Glucotrack, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.

Holders of 5% or more of GCTK

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Glucotrack, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of GCTK
HolderLatest formStakeChangeFirst filedLatest filingFiling
White Lion Capital LLC13G9.99%79.7K sharesNewSep 2, 20261 filingSep 2, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Glucotrack, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GCTK
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 2, 20266:15 PM ETWhite Lion Capital LLC13G9.99%79.7K sharesNewAug 26, 2026SEC
May 15, 202611:17 AM ETArmistice Capital, LLCand 1 other13G/A4.99%102.1K shares−5.00 ppfrom 9.99%Below 5%Mar 31, 2026SEC
Feb 17, 20269:49 PM ETArmistice Capital, LLCand 1 other13G9.99%101.1K sharesNewDec 31, 2025SEC
Feb 17, 20265:23 PM ETIkarian Capital, LLCand 1 other13G4.50%45.8K sharesNewBelow 5%Dec 31, 2025SEC
Jan 3, 20251:38 PM ETSabby Management, LLCand 2 others13G/A4.90%647.1K shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Glucotrack, Inc. shares.

No Form 144 notices for Glucotrack, Inc. are on file.